Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | — | IM |
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1283 (MNEXSPIKE PFS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. The concomitant medication was not reported by the reporter. The relevant medical history (vaccines within the past 4 weeks, medical conditions) was reported as unknown. It was reported that the patient had two adult children, both with exercise-induced asthma. She asked if they were eligible to receive mNEXSPIKE or if it was only for over 65 years old. She mentioned that she received the vaccine without any issues, except for a sore arm. She was confused as her pharmacist told her that the vaccine was for those 65 years and older. It was unknown if the patient experienced any additional symptoms or events. The treatment medication was not reported by the reporter.